Cyclacel Pharmaceuticals Inc., of Berkeley Heights, N.J., was issued Japanese Patent Nos. 5443763 and 5457196, which are related to pharmaceutical formulations of sapacitabine and methods of treating cancer comprising sapacitabine in combination with histone deacetylase inhibitors, respectively.